Herbalife Ltd. (NYSE:HLF - Get Free Report) Director Juan Miguel Mendoza purchased 2,500 shares of the firm's stock in a transaction dated Monday, November 4th. The stock was bought at an average cost of $7.98 per share, with a total value of $19,950.00. Following the purchase, the director now owns 122,500 shares of the company's stock, valued at approximately $977,550. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Juan Miguel Mendoza also recently made the following trade(s):
- On Monday, September 9th, Juan Miguel Mendoza purchased 10,000 shares of Herbalife stock. The stock was bought at an average cost of $7.11 per share, with a total value of $71,100.00.
- On Monday, August 26th, Juan Miguel Mendoza bought 10,000 shares of Herbalife stock. The shares were acquired at an average cost of $8.72 per share, with a total value of $87,200.00.
Herbalife Stock Down 0.3 %
Herbalife stock opened at $8.21 on Wednesday. Herbalife Ltd. has a 52 week low of $6.59 and a 52 week high of $15.66. The business has a 50-day simple moving average of $7.30 and a 200 day simple moving average of $9.29. The stock has a market cap of $826.98 million, a price-to-earnings ratio of 9.65, a PEG ratio of 0.27 and a beta of 1.17.
Video: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You
From Brownstone Research | Ad
“Hi, I’m Jeff Brown…
Even though I can’t see a thing…
I’m about to get in this Cybertruck and drive up to a location just a few miles from here to show you Elon Musk’s next AI product.
I promise what happens next will shock you…”
Click here to see what happened
Herbalife (NYSE:HLF - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.57 EPS for the quarter, topping the consensus estimate of $0.19 by $0.38. Herbalife had a negative return on equity of 18.66% and a net margin of 1.73%. The business had revenue of $1.24 billion during the quarter, compared to analysts' expectations of $1.23 billion. On average, research analysts anticipate that Herbalife Ltd. will post 1.51 earnings per share for the current year.
Institutional Investors Weigh In On Herbalife
Hedge funds have recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its stake in Herbalife by 465.3% during the second quarter. GAMMA Investing LLC now owns 3,533 shares of the company's stock worth $37,000 after purchasing an additional 2,908 shares during the last quarter. nVerses Capital LLC lifted its stake in shares of Herbalife by 240.0% in the 2nd quarter. nVerses Capital LLC now owns 5,100 shares of the company's stock valued at $53,000 after acquiring an additional 3,600 shares during the last quarter. Public Employees Retirement System of Ohio raised its position in Herbalife by 22.9% during the 1st quarter. Public Employees Retirement System of Ohio now owns 5,558 shares of the company's stock valued at $56,000 after purchasing an additional 1,035 shares during the last quarter. Van ECK Associates Corp raised its position in Herbalife by 10.3% during the 2nd quarter. Van ECK Associates Corp now owns 8,684 shares of the company's stock valued at $90,000 after purchasing an additional 808 shares during the last quarter. Finally, Foundry Partners LLC bought a new position in Herbalife during the 1st quarter valued at approximately $105,000.
Wall Street Analysts Forecast Growth
A number of research analysts have recently weighed in on the company. Citigroup dropped their target price on Herbalife from $16.00 to $13.00 and set a "buy" rating on the stock in a report on Friday, October 25th. B. Riley dropped their price target on Herbalife from $17.00 to $12.00 and set a "buy" rating on the stock in a report on Thursday, October 31st. DA Davidson dropped their price target on Herbalife from $13.00 to $7.50 and set a "neutral" rating on the stock in a report on Thursday, October 31st. StockNews.com upgraded Herbalife from a "hold" rating to a "buy" rating in a report on Monday. Finally, Mizuho boosted their target price on Herbalife from $8.00 to $9.00 and gave the company a "neutral" rating in a research note on Friday, November 1st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $10.42.
Check Out Our Latest Research Report on Herbalife
Herbalife Company Profile
(
Get Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
